An assessment of guidelines for prevention of ischemic stroke

Neurology

Volumn 59, Issue 7, 2002, Pages 977-982

  Hart, Robert G ^a   Bailey, Renee D ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; WARFARIN;

ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FINANCIAL MANAGEMENT; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL RISK;

EID: 0037044261     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.7.977     Document Type: Review

References (43)

1. Sainsbury R. Towards appropriate local surgery for patients with breast cancer. Lancet 2000;356:1124-1126.
2. Swales JD. Critical assessment of hypertension guidelines. In: Oparil S, Weber MA, eds. Hypertension: a companion to Brenner and Rector's the kidney. Baltimore: Saunders, 2000:375-382.
3. Shaneyfelt TM, Mayo-Smith MF, Rothwangel J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900-1905.
4. Miller J, Petrie J. Development of practice guidelines. Lancet 2000;355:82-83.
5. Field MJ, Lohr KN, eds. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press, 1990.
6. Appraisal of Guidelines for Research and Evaluation in Europe. Available at: http://www.agreecollaboration.org. Accessed November 2001.
7. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000;355:103-106.
8. Jones J, Hunter D. Consensus methods for medical and health services research. Br Med J 1995;311:376-380.
9. Guyatt G, Schunemann H, Cook D, Jaeschke R, Pauker S, Bucher H. Grades of recommendation for antithrombotic agents. Chest 2001;119(suppl):3S-7S.
10. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke. Stroke 2001;32:280-289.
11. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Supplement to the guidelines for the management of transient ischemic attacks. Stroke 1999;30:2502-2511.
12. Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998;29:554-562.
13. Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-1994.
14. Gorelick PB, Sacco RL, Smith DB, et al. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999;281:1112-1120.
15. European Stroke Initiative Executive Committee. European Stroke Initiative recommendations for stroke management. Cerebrovasc Disord 2000;10:335-351.
16. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Sixth ACCP Consensus Conference on Antithrombotic Therapy: antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001;119(suppl):300S-320S.
17. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: stroke prevention in patients with nonvalvular atrial fibrillation. Neurology 1998;51:671-673.
18. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Sixth ACCP Consensus Conference on Antithrombotic Therapy: antithrombotic therapy in atrial fibrillation. Chest 2001;119(suppl):194S-206S.
19. Royal College of Physicians of Edinburgh. Consensus Conference on Atrial Fibrillation in Hospital and General Practice, 3-4 September 1998. Br J Haematol 1999;104:195-196 (available at: http://www.rcpe.ac.uk/esd/consensus/atrial_fib_98.html; accessed November 2001).
20. Perry JR, Szalai JP, Norris JW, for the Canadian Stroke Consortium. Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis. Arch Neurol 1997;54:25-28.
21. Findlay JM, Tucker WS, Ferguson GG, Holness RO, Wallace MC, Wong JH. Carotid endarterectomy. Recommendations from the Canadian Neurosurgical Society. Can Med Assoc J 1997;157:653-659.
22. Royal College of Physicians of Edinburgh. Consensus Conference on Medical Management of Stroke, 26 and 27 May 1998. J Neurol Neurosurg Psychiatry 1999;66:128-129 (updated November 2000 at http://www.rcpe.ac.uk/esd/consensus/stroke_98.html; accessed November 2001).
23. South African Medical Association/Neurological Association of South Africa Stroke Working Group. Stroke therapy clinical guideline. S Afr Med J 2000;90:276-306.
24. Organizing Committees. Asia Pacific Consensus Forum on Stroke Management. Stroke 1998;29:1730-1736.
25. Intercollegiate Working Party for Stroke. National clinical guidelines for stroke. London: Royal College of Physicians of London, 2000. Available at: http://www.rcplondon:ac.uk/pubs/books/stroke/ceeu.stroke_clinicalll.htm. Accessed November 2001.
26. Scottish Intercollegiate Guidelines Network. Management of patients with stroke, II: management of carotid stenosis and carotid endarterectomy. SIGN publication no. 14, 1997. Available at: http://www.sign.ac.uk/guidelines/index.html. Accessed November 2001.
27. Scottish Intercollegiate Guidelines Network. Management of patients with stroke, I: assessment, investigation, immediate management and secondary prevention. SIGN publication no. 13, 1997. Available at: http://www.sign.ac.uk/guidelines/index. html. Accessed November 2001.
28. Scottish Intercollegiate Guidelines Network. Antithrombotic therapy. SIGN publication no. 36, 1999. Available at: http://www.sign.ac.uk/guidelines/index.html. Accessed November 2001.
29. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2001;38:1231-1265 (full guideline available at http://www.acc.org).
30. Thrombosis Interest Group of Canada. Practical treatment guidelines: prevention of stroke, antiplatelet therapy and stroke prevention in atrial fibrillation. Available at: http://www.tigc.org/eguidelines.htm.
31. Stroke Prevention and Educational Awareness Diffusion (SPREAD) Collaboration. The Italian Guidelines for stroke prevention. Neurol Sci 2000;21:5-12 (also accessible at http://www.spread.it).
32. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998;114:579S-589S.
33. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized clinical trials. Arch Intern Med 1994;154:1949-1957.
34. Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low-risk of stroke during treatment with aspirin. JAMA 1998;279:1273-1277.
35. Sinderman AD. Clinical trials, consensus conferences, and clinical practice. Lancet 1999;354:327-330.
36. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. Br Med J 2002;324:723-729.
37. Warlow C. Commentary. Who pays the guideline writers? Br Med J 2002;324:729-730.
38. Howitt A, Armstrong D. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. Br Med J 1999; 318:1324-1327.
39. Pearce LA, Hart RG, Halperin JL. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med 2000;109:45-51.
40. Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment of atrial fibrillation in Great Britain: variation in content and implications for treatment. Br Med J 1998;316:509-513.
41. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation. Stroke 1999;30:2547-2553.
42. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.
43. Benavente O, Moher D, Pham B. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. Br Med J 1998;317:1477-1480.